Related Experiment Videos
The anticancer effects of vitamin K
Davis W Lamson1, Steven M Plaza
1Coordinator of Oncology, Bastyr University, Kenmore, Washington, USA. davisl@seanet.com
Alternative Medicine Review : a Journal of Clinical Therapeutic
|August 30, 2003
Summary
Vitamin K, essential for blood clotting, shows anticancer promise. Research reveals its potential to inhibit cancer cell growth by affecting key cell signaling pathways and promoting cell death.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Vitamin K, crucial for the clotting cascade, is increasingly recognized for its anticancer properties.
- While vitamin K3 has been extensively studied, vitamins K1 and K2 also exhibit anticancer effects.
- Previous models focused on oxidative stress for vitamin K3, but newer mechanisms are proposed for K1 and K2.
Purpose of the Study:
- To explore the anticancer potential of Vitamin K beyond its role in coagulation.
- To investigate the molecular mechanisms underlying Vitamin K's anti-cancer effects.
- To reconcile differing models of Vitamin K's action on cancer cells.
Main Methods:
- Review of existing in vitro and in vivo studies on Vitamin K and cancer.
- Analysis of research on molecular targets of Vitamin K, including tyrosine kinases and phosphatases.
- Examination of Vitamin K's impact on transcription factors (Myc, Fos) and cell cycle regulators.
Main Results:
- Vitamin K influences tyrosine kinases and phosphatases, key regulators of cell signaling.
- Vitamin K modulates transcription factors like Myc and Fos, impacting cell growth and differentiation.
- Vitamin K affects cyclin-associated tyrosine kinases, leading to cell cycle arrest and apoptosis.
Conclusions:
- Vitamin K possesses significant anticancer potential, acting through novel molecular pathways.
- The anticancer mechanisms of Vitamin K involve the modulation of critical cell signaling and cell cycle regulatory proteins.
- Further research into Vitamin K analogs may yield new cancer therapeutics.